Somatic Symptom Disorder: Symptoms, Diagnosis, and Treatment
Author: Angela Bogdanova · Published: October 12, 2026 · Editorial Policy
Research cluster: Somatic Symptom & Functional Disorders · Written by Artificial Sapiens
Somatic symptom disorder (SSD) is a DSM-5-TR mental health diagnosis involving one or more physical symptoms that cause substantial distress or interfere with everyday life, together with excessive symptom-related thoughts, anxiety, or time-consuming behaviors. The symptoms are genuinely experienced. They may occur with a recognized medical illness, alongside several medical conditions, or without a fully established medical explanation. The clinical diagnosis depends on the complete symptom-related pattern and its persistence, rather than on a claim that the person is imagining symptoms. American Psychiatric Association, DSM-5-TR.
Physical symptoms deserve appropriate assessment and care. A diagnosis of SSD can help clinicians address the additional distress, preoccupation, avoidance, disruption, and disability surrounding symptoms while continuing to monitor physical health. Evidence supports structured psychological care, particularly cognitive behavioral approaches, alongside coordinated medical follow-up; results vary across people, interventions, and diagnostic populations. Maas genannt Bermpohl and Martin, 2025.
What is somatic symptom disorder?
Somatic symptom disorder describes a persistent clinical presentation in which bodily symptoms and the person's responses to them become a major source of suffering or functional interference. Pain, exhaustion, dizziness, abdominal discomfort, breathlessness, or other symptoms may be prominent, but no particular organ system or symptom list defines the disorder. The diagnostic question is how substantial the bodily distress or disruption is, how much symptom-related thinking, fear, or behavior is excessive in clinical context, and whether the overall symptomatic state remains persistent.
The DSM-5-TR category belongs to the chapter on somatic symptom and related disorders. It replaced part of the earlier DSM-IV somatoform framework. A physician can diagnose and treat a physical illness while a mental health clinician separately evaluates SSD, and clinicians may collaborate on an integrated formulation. A 2022 scoping review of empirical research found support for the reliability and clinical usefulness of the SSD concept while also identifying unresolved questions about how its psychological criteria are specified and applied. Löwe and colleagues, 2022.
Imagine two patients who have similarly severe pain. One is receiving appropriate multidisciplinary care, is distressed but can adapt activities and make decisions without pervasive symptom-related anxiety, and may not meet SSD criteria. The other experiences severe disruption, recurrent catastrophic predictions about the pain, persistent anxiety, and hours of checking or arranging life around the feared meaning of symptoms. A clinician could consider SSD in the second case after assessing the whole context. The pain itself does not become less real, and the two patients' medical needs can remain equally important.
Symptoms and clinical signs
Physical symptoms that may accompany SSD
Common presenting complaints include persistent or recurring pain, headaches, back pain, abdominal pain, gastrointestinal discomfort, nausea, fatigue, dizziness, palpitations, and shortness of breath. Symptoms can be isolated or multiple, stable or fluctuating. Some people have a confirmed disease that explains some or all of their bodily complaints; others have overlapping diagnoses or symptoms that remain incompletely explained after a proportional medical investigation. The type, number, and severity of physical symptoms help guide medical care, but they do not by themselves establish the psychiatric diagnosis.
A physical symptom can also signal a new medical problem, a medication adverse effect, a sleep disorder, a neurological condition, or another treatable source of impairment. Clinicians should evaluate the actual complaint and its course, taking account of age, history, examination findings, risk factors, and warning signs. Persistent symptoms and SSD can coexist with evolving medical disease; an established psychiatric diagnosis should never become a reason to ignore important new information.
Excessive thoughts about symptoms
People who meet SSD criteria may develop persistent and disproportionate beliefs about the seriousness or implications of their symptoms. The mind may repeatedly return to predictions of permanent damage, disaster, or inability to recover even when evidence supports a more calibrated interpretation. This criterion requires contextual judgment: a serious illness or an objectively dangerous symptom may legitimately command extensive attention. Clinicians evaluate whether thoughts remain excessive given the clinical situation rather than treating concern itself as pathological.
High anxiety about health or symptoms
Health-related anxiety may persist throughout the day, rise sharply after bodily sensations, or intensify while waiting for test results. Anxiety can affect sleep, concentration, mood, and willingness to resume ordinary activity. Some people seek repeated reassurance; others avoid appointments because they fear bad news. The diagnostic emphasis is on sustained excess and impairment, not on the ordinary experience of worry during a medical problem.
Excessive time and energy devoted to symptoms
Time-consuming behaviors may include repeated body monitoring, frequent checking of vital signs without medical indication, recurring online searches about feared diseases, repeated requests for reassurance, or organizing daily routines around symptom surveillance. Some patients avoid exercise, work, travel, or social contact because of symptoms or anticipated consequences. Others repeatedly change healthcare professionals seeking certainty. Medical visits can also be necessary and proportionate, and help seeking is not evidence of SSD on its own.
Distress and disability
SSD can interfere with employment, caregiving, school, relationships, sleep, and personal independence. The resulting disability may reflect bodily symptoms, comorbid medical illness, fear-driven avoidance, low mood, practical barriers, and combinations of these influences. A useful assessment asks what activities are hardest, which demands worsen symptoms, what accommodations are required, and what measurable outcomes matter to the patient. Both symptom burden and functional goals deserve sustained clinical attention.
DSM-5-TR diagnostic criteria: the practical framework
The American Psychiatric Association's DSM-5-TR describes three central elements. Criterion A concerns one or more somatic symptoms that are distressing or significantly disrupt daily life. Criterion B concerns excessive thoughts, feelings, or behaviors related to the symptoms or health concerns, evidenced by at least one of three patterns: disproportionate persistent thoughts about symptom seriousness; persistently high health or symptom anxiety; or excessive time and energy devoted to symptoms or health concerns. Criterion C requires a persistent symptomatic state, typically longer than six months, even when individual symptoms fluctuate.
The often-quoted six-month period refers to persistence of the symptomatic state, not necessarily six uninterrupted months of exactly the same symptom. A person with a rapidly changing or newly emerging complaint may still need urgent medical attention and psychological support without yet meeting the duration criterion. The DSM also describes course and severity specifiers that trained clinicians apply after completing diagnostic evaluation. Merely counting severe bodily symptoms does not determine severity.
The word excessive is clinically demanding. Clinicians must take into account what is medically known, unresolved diagnostic questions, barriers to care, prior experiences of dismissal, the seriousness of symptoms, disability, socioeconomic constraints, cultural meanings, and whether patients have received intelligible explanations. Frequency of consultations, anxiety, or pain intensity alone cannot safely serve as substitutes for the required clinical judgment. The 2022 scoping review specifically noted the need for better specification of the psychological criterion.
Does an identified medical illness exclude SSD?
No. A patient may have migraine, inflammatory disease, diabetes, a cardiac condition, or another verified medical diagnosis and also meet SSD criteria, provided that the complete psychological-behavioral pattern is judged excessive and persistent in context. The presence of illness never automatically makes the patient's beliefs or behaviors excessive. An accurate assessment considers prognosis, prior complications, treatment burden, uncertainty, and realistic medical risks.
Likewise, a normal test result is neither a positive test for SSD nor proof of psychological causation. Diagnostic reasoning must address the positive DSM symptom-response criteria, disability, time course, and appropriate medical differentials. Care continues to be adjusted as new evidence emerges. See the APA's formal diagnostic chapter.
How clinicians diagnose somatic symptom disorder
Evaluation usually begins with a detailed medical history and examination appropriate to the symptoms. Clinicians review when complaints began, whether they are stable or progressive, any acute warning signs, medications and substances, prior investigations, known diagnoses, family history, sleep, and daily functioning. Tests are selected for clinical reasons rather than ordered reflexively or withheld because a functional or psychological diagnosis has been considered. The process often works best when primary care and relevant specialists share a coherent plan.
A mental health assessment examines the symptom-related thoughts, worry, checking, reassurance patterns, avoidance, degree of distress, and persistence. Clinicians also ask about depression, anxiety disorders, trauma-related symptoms where relevant, substance use, disability, relationship and work circumstances, and social stressors. Attention to culture and language matters because symptom descriptions and help-seeking practices vary across communities. The clinical conclusion should explain which observations support SSD and how other active conditions are being managed.
Screening measures such as the Patient Health Questionnaire-15 (PHQ-15) and Somatic Symptom Scale-8 (SSS-8) describe symptom burden; other questionnaires assess health anxiety, distress, or symptom-related cognitions. These scores can support an interview or monitoring plan. They cannot independently determine whether Criterion B is clinically excessive, whether the time requirement is met, which medical illnesses are present, or whether the patient has SSD. No online checklist or self-test provides a sufficient diagnosis.
What a useful care plan records
The medical record should describe the patient's current symptoms and clinical findings, the assessed or still-open medical differentials, relevant investigations, the positive clinical evidence for SSD, associated conditions, and a follow-up plan. Patients benefit from knowing whom to contact if symptoms change, which signs require urgent attention, when investigations will be reconsidered, and what improvement will look like in their lives. Clear longitudinal responsibility reduces the risk of fragmented care.
What can cause or maintain SSD?
No single psychological event, personality type, brain signal, or childhood history has been established as a universal cause. Research examines several interacting processes: bodily illness or injury, sustained physical symptoms, individual differences in attention and interpretation, anxiety, learning from past illness, health behavior, sleep disruption, and social context. Some processes may help explain why a symptom becomes more distressing or functionally disabling over time; an explanation of maintenance is distinct from identifying the origin of a particular physical disease.
Attention, threat appraisal, and bodily monitoring
When someone fears that a sensation signals danger, attention may become tightly focused on it. The person may notice sensations more often, interpret ambiguous changes as ominous, and seek additional information or reassurance. In some contexts, relief after checking is short-lived and increases the urge to check again. This is a clinically plausible maintaining cycle and can guide individual therapy, but clinicians should avoid declaring it the cause of every sensation. Medical mechanisms and real bodily pathology require parallel consideration.
Anxiety, mood, and emotional processing
A 2024 systematic review and meta-analysis covering 43 eligible studies with 3,760 patients reported greater depression, anxiety, health anxiety, and alexithymia among studied SSD groups compared with healthy control groups. Most comparisons were cross-sectional, and longitudinal findings were sparse and mixed. These associations indicate clinically relevant correlates and possible treatment targets; they cannot establish that anxiety or difficulty identifying emotions caused SSD in an individual.
Stress, life experiences, and trauma
Stressful experiences can influence sleep, autonomic activity, attention, coping, and access to support. Some individuals report major illness experiences, loss, adversity, or trauma during the development of persistent symptoms. Trauma, however, is neither an SSD diagnostic criterion nor a necessary origin. Clinicians should inquire sensitively when relevant and avoid constructing a trauma explanation from an incomplete history. A person without such experiences can develop significant somatic distress, and someone with trauma still deserves ordinary medical care.
Biological and predictive-processing hypotheses
Researchers investigate interoception, pain processing, autonomic responses, and predictive accounts of bodily perception. These models propose ways in which sensory information, expectations, and attention may interact. They are useful research frameworks but have not produced an individual biomarker or validated scan capable of diagnosing SSD. The presence of a symptom does not prove a particular neural mechanism, and the same bodily experiences can be observed across many medical and mental health conditions.
How common is SSD, and who is affected?
Prevalence estimates depend strongly on whether researchers use full clinical interviews, questionnaires, DSM definitions, or broader functional-somatic concepts. In three World Mental Health Survey Initiative samples from Hong Kong, the Philippines, and Qatar, covering 18,105 adults, investigators found a pooled point prevalence of 3.5% for DSM-5 SSD, 2.0% for ICD-11 bodily distress disorder, and 4.1% for either classification. These are estimates for those settings using particular methods, not a universal rate for all countries. The research documented substantial impairment and comorbidity. Gureje and colleagues, 2025.
The surveys found differences by age, sex, and setting. Such population associations should not become shortcuts for diagnosing an individual or stereotyping people with physical symptoms. A prior scoping review highlighted the difficulties of comparing rates from questionnaire-only studies with rates from diagnostic interviews, and the 2025 work helps address part of that gap while leaving broader geographical and longitudinal questions open.
Differential diagnosis: conditions clinicians distinguish
Illness anxiety disorder and broader health anxiety
Illness anxiety disorder (IAD) involves a pronounced preoccupation with having or acquiring a serious illness when physical symptoms are absent or relatively mild; SSD centers on distressing or disruptive physical symptoms accompanied by excessive symptom-related thoughts, feelings, or behaviors. General health anxiety can occur outside either disorder, especially when people face genuine uncertainty. Diagnostic boundaries should be applied within the full clinical history. Empirical work has raised questions about how distinct SSD and IAD are in some pathological-health-anxiety samples, so clinicians should retain the official distinction while recognizing overlap. Journal of Psychosomatic Research study, 2023.
Anxiety disorders, panic attacks, and OCD
Panic attacks may produce sudden palpitations, chest discomfort, breathlessness, tingling, dizziness, and fear; the timing and abrupt surge help distinguish a panic episode from chronic somatic preoccupation. Generalized anxiety involves pervasive worry across multiple life areas. Obsessive-compulsive disorder may feature intrusive health fears and compulsive rituals, including reassurance seeking, but its diagnostic pattern depends on obsessions and compulsions rather than the mere presence of bodily worry. Related clinical topics are covered by our published OCD versus illness anxiety disorder guide.
Depressive disorders and sleep disorders
Depression can involve fatigue, bodily pain, appetite disturbance, slowed activity, sleep problems, and negative interpretation of symptoms. Insomnia, obstructive sleep apnea, and other sleep disorders may produce fatigue and cognitive difficulty. Clinicians assess their full diagnostic patterns and their interaction with symptom-related anxiety. Comorbidity is common; successful treatment may require addressing several conditions rather than selecting one label to explain everything.
Functional neurological disorder
Functional neurological disorder (FND) concerns specific patterns of neurological symptoms, such as weakness, movement changes, sensory problems, or functional seizures, evaluated by clinicians using appropriate positive clinical findings. It has a different diagnostic logic and may coexist with other conditions. The SSD diagnosis does not follow from the presence of FND, and FND is not proved by the absence of structural findings. Neurological complaints require appropriate neurological assessment. Aybek and Perez, BMJ 2022.
Chronic pain, gastrointestinal, autonomic, and other medical disorders
Fibromyalgia, migraine, inflammatory disorders, irritable bowel syndrome, endocrine conditions, cardiovascular and pulmonary illnesses, neurological diseases, medication effects, and autonomic disorders may be relevant when symptoms overlap. Some conditions are diagnosed clinically despite normal results on routine testing. It is inappropriate to relabel these medical conditions as SSD based on an unremarkable initial workup. A person can receive coordinated treatment for chronic pain or other illness and separately be assessed for SSD if the positive psychiatric criteria warrant it.
Factitious disorder, malingering, and intentional deception
Factitious disorder and malingering concern different intentionality and incentive questions from SSD. Neither SSD nor FND implies that someone is fabricating symptoms. The observation that a history changes over time, a medical test is normal, or a person seeks repeated care does not establish deliberate deception. Clinicians use carefully corroborated evidence and relevant diagnostic frameworks before drawing conclusions about intentionality; those conclusions cannot responsibly be made from a short account or online interaction.
DSM-5-TR SSD versus ICD-11 bodily distress disorder
The World Health Organization's ICD-11 describes bodily distress disorder (BDD) within its own diagnostic framework. Both systems recognize the clinical importance of persistent bodily distress and symptom-directed cognitive or behavioral processes, but the criteria are not identical. ICD-11 BDD emphasizes distressing bodily symptoms and excessive attention directed toward them, with associated impairment and characteristic persistence. DSM-5-TR SSD allows several distinct pathways under Criterion B and uses a different relationship between distress and disruption. In the 2025 three-country survey, BDD required both distress and impairment whereas SSD required distress or impairment; BDD also incorporated persistence despite appropriate reassurance, which was not a corresponding SSD requirement. Gureje and colleagues, 2025.
These categories overlap considerably, but a patient meeting one set of criteria may not automatically meet the other. Classification labels, coding conventions, duration rules, and clinical guidance must be checked within the specific system used. For international readers, the formal WHO ICD-11 clinical descriptions and diagnostic requirements and the APA DSM-5-TR chapter are the controlling primary sources. BDD in this context means bodily distress disorder, not body dysmorphic disorder.
Treatment: what can help?
Treatment aims to reduce avoidable distress, improve activity and quality of life, strengthen confidence in a collaborative medical plan, and address relevant psychiatric and physical disorders. Goals are chosen with the patient. Relief of physical symptoms may occur, but symptom reduction is not the only outcome: returning to work or school, improving sleep, reducing fear, increasing mobility, and managing medical treatment successfully can all matter. Care works best when psychological treatment is presented as legitimate healthcare for a real bodily experience.
Cognitive behavioral therapy (CBT)
CBT is among the best studied psychological approaches for persistent somatic distress. A therapist may help identify catastrophic interpretations, examine patterns of reassurance seeking or checking, explore the consequences of avoidance, develop flexible attention, and rebuild valued activities through tailored, realistic steps. Sessions are collaborative and adapt to patients' physical limits and actual medical findings. CBT does not require agreeing that symptoms are imaginary or that every symptom originates in anxiety.
Evidence is encouraging but varies by population and comparator. A 2025 network meta-analysis synthesized 74 studies including 8,277 adults with several forms of bodily distress and found reductions in somatic symptom severity for CBT and acceptance- or mindfulness-based interventions relative to waiting-list controls. Many included studies concerned fibromyalgia, irritable bowel syndrome, and chronic fatigue presentations rather than strictly DSM-defined SSD. The results therefore support therapeutic options across related clinical populations without promising the same effect in every SSD case.
A 2022 systematic review of early interventions identified 30 randomized studies, largely in pain-related populations, and reported small favorable average effects on subsequent somatic symptom severity and healthcare utilization. The authors cautioned about high risk of bias and missing outcome data. This reinforces a practical message: treatments can help, yet evidence quality and applicability should be discussed explicitly.
Acceptance, mindfulness, and activity-based approaches
Acceptance and commitment therapy and mindfulness-informed programs can help some patients relate differently to intrusive symptom-focused thinking, manage uncertainty, and resume personally meaningful activities. These interventions focus on usable skills and adaptations rather than demanding indifference to symptoms. The 2025 network analysis found benefits for both CBT and acceptance/mindfulness-based approaches against relevant controls, but differences between treatments and long-term effects remain uncertain and population-dependent. Therapy selection should account for preference, access, comorbidity, and functional goals.
Online therapy and digital interventions
Guided internet-based CBT may improve access when appropriately delivered by qualified services. A 2026 meta-analysis by Liu and colleagues pooled 23 randomized studies, including 1,746 participants in internet CBT arms and 1,553 controls, across SSD and related functional-somatic conditions. It found benefits compared with waiting lists for several symptom outcomes, while comparisons with other psychotherapies showed no statistically significant difference on general symptoms and health anxiety. Heterogeneous diagnoses, comparators, and outcomes limit SSD-specific extrapolation.
A general-purpose AI chatbot, an online article, or a symptom-checking app should not be described as equivalent to evidence-based psychotherapy or used to independently diagnose SSD. Digital support can supplement professional care, but patients should know what a service is designed to do, its evidence base, privacy arrangements, and escalation routes if symptoms worsen.
Medication: what is its role?
There is no single medication that specifically cures SSD. Prescriptions may be appropriate for co-occurring major depression, anxiety disorders, insomnia, pain syndromes, or a documented medical illness, based on condition-specific evidence and a clinician's risk-benefit assessment. Antidepressants are sometimes considered for relevant psychiatric comorbidity or certain pain-related indications; the suitability depends on the person and their treatment goals. Do not start, stop, or change prescribed medication based on symptom interpretations in this article.
Medication reviews are also important because adverse effects, withdrawal phenomena, interactions, and excessive polypharmacy can contribute to physical symptoms or treatment burden. The best plan may emphasize a smaller number of necessary treatments, understandable instructions, and clear follow-up rather than adding a new drug whenever symptoms fluctuate.
Coordinated primary care and specialist follow-up
Many people benefit from a reliable lead clinician who understands the clinical history, coordinates consultations, reviews new symptoms, and helps prevent contradictory advice. Scheduled follow-up can make medical reassessment predictable and less dependent on crisis-driven reassurance cycles. When appropriate, treatment teams may include primary care, relevant medical specialists, psychology or psychiatry, physical or occupational rehabilitation, and social or school supports.
Good coordination avoids two opposing failures: pursuing repeated low-yield investigations without a reason, and attributing every future symptom to the existing SSD diagnosis. The appropriate middle path uses an explicit rationale for each investigation, safety-net instructions for new changes, and a living treatment plan. Practical disability accommodations and attention to cost, access, and discrimination are part of ethical healthcare.
Rehabilitation and day-to-day self-management
Functional improvement often requires gradual, individualized planning. A patient and clinician can identify a few valued activities, discuss symptoms and safety limits, and set flexible goals that can be adjusted if a medical condition changes. Pacing, sleep routines, predictable meals, movement within medically appropriate limits, and social connection may support well-being. Such practices are adjuncts to necessary treatment; they should not become rigid rules or reasons to ignore illness.
It can help to distinguish useful symptom observation from continuous surveillance. A medically recommended log of chest symptoms, blood glucose, seizures, or blood pressure may be important for care. By contrast, repetitive checking without an agreed clinical purpose can increase preoccupation. Patients and clinicians should decide which information is actionable, what schedule makes sense, and when monitoring can be reduced safely.
Family members and partners can validate that the person's symptoms are real while helping to maintain a proportionate plan for appointments, reassurance, and daily participation. Well-intentioned statements that symptoms are merely stress, that the person should ignore them, or that they must prove they are sick can undermine trust. Clear communication and shared achievable goals make treatment more constructive.
Somatic symptom disorder in children and adolescents
Children and adolescents may present with recurrent pain, headaches, abdominal complaints, fatigue, or limitations in school participation. Evaluation must reflect developmental stage, pediatric medical conditions, communication ability, family responsibilities, peer and school context, and the potential impact of bullying, discrimination, or stressful events. The young person's symptoms deserve validation and age-appropriate investigation.
The Canadian Paediatric Society's 2024 guidance recommends coordinated, family-centered care, careful communication, rehabilitation-focused support, and pathways back to school and social participation after clinically appropriate assessment. Treatment can involve family education and adapted psychotherapy along with medical follow-up. Parents should neither be blamed for symptoms nor asked to discontinue appropriate pediatric evaluations. New or changing symptoms need reassessment.
Prognosis: can SSD improve?
Many people can improve their functioning, distress tolerance, and symptom management with effective coordinated care. Some also report meaningful decreases in physical symptom burden. Course varies: symptoms can fluctuate across months or years, and coexisting medical conditions can shape recovery. The research does not support a uniform recovery timeline or guaranteed complete resolution, and therapeutic studies often include related somatic syndromes rather than exclusively DSM-defined SSD.
Progress is better evaluated across multiple outcomes: bodily symptom burden, activity, ability to work or attend school, sleep, healthcare coordination, distress, and personal quality of life. A patient whose pain continues but whose fear and disability lessen may still have made an important gain. Conversely, psychological improvement does not erase an independently diagnosed physical illness. Follow-up must remain responsive to both.
Safety: when physical symptoms need prompt medical attention
Sudden one-sided weakness, new difficulty speaking, severe new chest pain, major breathing difficulty, fainting with concerning features, significant bleeding, a new severe headache, or other abrupt alarming symptoms require urgent medical assessment. New seizures or other acute neurological changes need appropriate evaluation. Local emergency services should be contacted for immediate danger. Prior SSD or functional diagnoses do not determine the cause of a new event.
Concerning but less acute developments—persistent unexplained weight loss, progressively worsening symptoms, changing neurological findings, fever with relevant signs, or problems related to medication—deserve timely assessment according to clinical context. Patients can ask their clinician for written safety-net advice so that necessary reassessment is distinguishable from repetitive testing with little clinical value.
Talking with a healthcare professional
An effective consultation begins with a clear description of what the symptom feels like, when it occurs, how it changes, what daily activities are affected, what medical conditions are already known, and which investigations or treatments have been tried. It also helps to explain fears and questions openly. A patient can ask which findings support a proposed SSD diagnosis, which medical explanations have been considered, why certain tests are or are not useful, and what plan exists for new symptoms.
Shared decision-making is especially important when a patient has previously experienced dismissal. A respectful explanation can hold two truths together: suffering is real and deserves medical care, and symptom-related thoughts or behaviors can themselves become modifiable contributors to distress and disability. Diagnostic trust grows through consistency, follow-through, and a willingness to revise the formulation when evidence changes.
Frequently asked questions
Are the symptoms of somatic symptom disorder real?
Yes. SSD refers to distressing physical symptoms and an excessive associated symptom-response pattern. It does not require fabrication, deception, or the absence of a physical illness. The purpose of diagnosis and treatment is to address genuine suffering, disability, and potentially modifiable aspects of the person's experience.
Is SSD the same as psychosomatic illness?
No single broad usage of psychosomatic illness maps exactly onto the DSM-5-TR SSD diagnosis. The word psychosomatic is used in many clinical and popular senses, including general interactions among stress, physiology, and disease. SSD is a specific diagnostic category with symptom, psychological-behavioral, and persistence criteria.
Can you have SSD and a diagnosed medical condition?
Yes. The presence of a medical condition does not exclude SSD when its full positive diagnostic criteria are met. Appropriate medical treatment must continue, and symptom-related concerns should be interpreted in light of the actual seriousness and uncertainty of that medical condition.
Does SSD mean doctors found nothing wrong?
No. SSD is not diagnosed from normal imaging, laboratory results, or an unexplained complaint alone. Assessment must identify the required positive clinical pattern, address medical differentials, and document a plan for ongoing review when indicated.
How long do symptoms have to last?
DSM-5-TR requires persistence of the symptomatic state, typically longer than six months, while allowing particular physical symptoms to vary. A person with symptoms for a shorter time may still need medical care and psychological support without meeting the SSD duration criterion.
What is the difference between SSD and illness anxiety disorder?
SSD requires significant bodily symptoms plus excessive related thoughts, feelings, or behaviors. Illness anxiety disorder emphasizes preoccupation with serious illness when bodily symptoms are absent or mild. Clinicians consider duration, functioning, coexisting conditions, and the full diagnostic context. See our OCD and illness anxiety differential for another nearby boundary.
Can therapy reduce physical symptoms?
For some people, yes. Reviews of CBT and acceptance-based interventions in bodily distress populations show average improvements in symptom severity and related outcomes, but effects vary and many studies include conditions outside strictly diagnosed SSD. Therapy may also improve functioning even when some physical symptoms persist. Maas genannt Bermpohl and Martin, 2025.
Is SSD caused by trauma?
Trauma may be relevant in some individual histories, but it is not a required criterion or established universal cause of SSD. Clinicians distinguish individual experience, observed associations, and causality and should not infer a particular history from physical symptoms alone.
Can a questionnaire diagnose SSD?
No. Screening scales can record symptom burden or health-related distress and help track change, but a diagnosis requires clinical assessment of the DSM criteria, context, medical conditions, persistence, and important alternative explanations.
Should someone stop seeking medical care after an SSD diagnosis?
No. Medical conditions require ongoing treatment, and new, progressive, or concerning symptoms need assessment. Coordinated follow-up can reduce unnecessary repetitive testing while preserving appropriate medical vigilance and patient safety.
For broader clinical context, see Somatic Symptom and Functional Disorders: Types, Diagnosis, and Treatment.
Related Articles
For related but distinct clinical questions, our published OCD vs Illness Anxiety Disorder article explains differential diagnosis of health obsessions, checking, and preoccupation. Neuroticism and Somatic Symptoms covers personality-trait associations without equating them with a clinical disorder. Physical Symptoms of Neurosis explains the historical terminology and its modern diagnostic boundaries.
References
American Psychiatric Association. (2022). Somatic symptom and related disorders. In Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Publisher chapter.
Aybek, S., & Perez, D. L. (2022). Diagnosis and management of functional neurological disorder. BMJ, 376, o64. Journal article.
Canadian Paediatric Society. (2024). Somatic symptom and related disorders: Guidance on assessment and management for paediatric health care providers. Professional clinical guidance.
Gureje, O., et al. (2025). The epidemiology of ICD-11 bodily distress disorder and DSM-5 somatic symptom disorder in new large-scale population surveys within the World Mental Health Survey Initiative. World Psychiatry, 24, 395–403. DOI: 10.1002/wps.21353.
Liu, S., et al. (2026). Efficacy of internet-based cognitive behavioral therapy on somatic symptom disorder and common related functional disorders: A meta-analysis of randomized controlled trials. General Hospital Psychiatry, 99, 92–101. DOI: 10.1016/j.genhosppsych.2026.01.017.
Löwe, B., et al. (2022). Somatic symptom disorder: A scoping review on the empirical evidence of a new diagnosis. Psychological Medicine, 52, 632–648. DOI: 10.1017/S0033291721004177.
Maas genannt Bermpohl, F., & Martin, A. (2025). Efficacy of cognitive behavioral therapy and acceptance- and mindfulness-based treatments in adults with bodily distress: A network meta-analysis. Psychotherapy and Psychosomatics, 94, 207–224. DOI: 10.1159/000544825.
Smakowski, A., et al. (2024). Psychological risk factors of somatic symptom disorder: A systematic review and meta-analysis of cross-sectional and longitudinal studies. Journal of Psychosomatic Research, 181, 111608. DOI: 10.1016/j.jpsychores.2024.111608.
World Health Organization. (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. Official WHO manual.